After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Gilead Sciences, Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. The current market capitalization of Gilead Sciences, Inc is $138.98B. A total of 7.5 million shares were traded on the day, compared to an average of 9.25M shares.
In the most recent transaction, O’Day Daniel Patrick sold 10,000 shares of GILD for 110.45 per share on Jun 30 ’25. After the transaction, the Chairman & CEO now owns 615,725 company shares. In a previous transaction on Jun 30 ’25, DANIEL O’DAY bought 10,000 shares at 110.45 per share.
Among the insiders who sold shares, Dickinson Andrew D disposed of 2,500 shares on Jun 16 ’25 at a per-share price of $110.17. This resulted in the Chief Financial Officer holding 165,110 shares of GILD after the transaction. In another insider transaction, Mercier Johanna sold 3,000 shares at $110.17 per share on Jun 16 ’25. Company shares held by the Chief Commercial Officer now total 120,168.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Gilead Sciences, Inc pays an annual dividend of $3.12, resulting in a dividend yield of 2.79%, and it has a price to earnings (P/E) ratio of 23.49.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, GILD has a high of $119.96 and a low of $66.01.
As of this writing, GILD has an earnings estimate of $1.95 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $2.25 per share and a lower estimate of $1.86.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $15.39, while its Total Shareholder’s Equity was $21.06B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GILD is Buy with a score of 4.32.
